Fortress Biotech, Inc.
FBIO
$1.63
-$0.015-0.92%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 57.26M | 58.85M | 76.20M | 83.77M | 80.93M |
| Total Receivables | 10.40M | 10.85M | 10.69M | 10.12M | 15.39M |
| Inventory | 14.43M | 11.79M | 9.69M | 10.58M | 10.21M |
| Prepaid Expenses | 7.11M | 2.58M | 4.65M | 12.07M | 10.50M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.17M | 2.21M | 2.21M | -- | -- |
| Total Current Assets | 90.37M | 86.28M | 103.44M | 116.55M | 117.02M |
|
|
|||||
| Total Current Assets | 90.37M | 86.28M | 103.44M | 116.55M | 117.02M |
| Net Property, Plant & Equipment | 17.12M | 17.56M | 18.17M | 22.59M | 23.50M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 31.86M | 17.84M | 18.66M | 19.47M | 20.29M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.87M | 5.41M | 5.42M | 6.03M | 6.72M |
| Total Assets | 144.22M | 127.09M | 145.69M | 164.65M | 167.53M |
|
|
|||||
| Total Accounts Payable | 31.64M | 34.03M | 37.96M | 41.80M | 34.81M |
| Total Accrued Expenses | 30.74M | 27.04M | 27.75M | 31.77M | 34.68M |
| Short-term Debt | -- | -- | -- | 4.02M | 3.93M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.25M | 3.76M | 5.48M | 5.60M | 5.52M |
| Total Finance Division Other Current Liabilities | 5.77M | 5.47M | 4.36M | 4.50M | 5.97M |
| Total Other Current Liabilities | 5.77M | 5.47M | 4.36M | 4.50M | 5.97M |
| Total Current Liabilities | 71.40M | 70.31M | 75.54M | 87.70M | 84.91M |
|
|
|||||
| Total Current Liabilities | 71.40M | 70.31M | 75.54M | 87.70M | 84.91M |
| Long-Term Debt | 57.96M | 52.47M | 67.01M | 61.42M | 60.86M |
| Short-term Debt | -- | -- | -- | 4.02M | 3.93M |
| Capital Leases | 14.75M | 15.29M | 15.93M | 17.62M | 18.28M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.76M | 1.75M | 1.80M | 1.85M | 1.89M |
| Total Liabilities | 145.87M | 139.82M | 160.28M | 168.58M | 165.94M |
|
|
|||||
| Common Stock & APIC | 763.60M | 755.26M | 739.11M | 733.31M | 717.41M |
| Retained Earnings | -740.87M | -734.10M | -721.24M | -710.29M | -694.87M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 22.73M | 21.16M | 17.87M | 23.02M | 22.54M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
|
|
|||||
| Total Common Equity | 22.73M | 21.16M | 17.87M | 23.02M | 22.54M |
| Total Preferred Equity | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
| Total Minority Interest | -24.38M | -33.90M | -32.48M | -26.96M | -20.96M |
| Total Equity | -1.64M | -12.74M | -14.60M | -3.94M | 1.59M |
|
|
|||||